Abstract
Glioma is the most common type of primary brain tumor, and it has a high mortality rate. Currently, there are only a few therapeutic approaches for gliomas, and their effects are unsatisfactory. Therefore, uncovering the pathogenesis and exploring more therapeutic strategies for the treatment of gliomas are urgently needed to overcome the ongoing challenges. Cellular redox imbalance has been shown to be associated with the initiation and progression of gliomas. Among reactive oxygen species (ROS), hydrogen peroxide (H2O2) is considered the most suitable for redox signaling and is a potential candidate as a key molecule that determines the fate of cancer cells. In this review, we discuss the potential cellular and molecular roles of H2O2 in gliomagenesis and explore the potential implications of H2O2 in radiotherapy and chemotherapy and in the ongoing challenges of current glioma treatment. Moreover, we evaluate H2O2 as a potential redox sensor and potential driver molecule of nanocatalytic therapeutic strategies for glioma treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akerfelt M, Morimoto RI, Sistonen L (2010) Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 11(8):545–555. https://doi.org/10.1038/nrm2938
Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, Weill B, Goldwasser F (2006a) Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119(1):41–48. https://doi.org/10.1002/ijc.21685
Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Goldwasser F, Batteux F (2006b) Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 98(4):236–244. https://doi.org/10.1093/jnci/djj049
Amatya VJ, Naumann U, Weller M, Ohgaki H (2005) TP53 promoter methylation in human gliomas. Acta Neuropathol 110(2):178–184. https://doi.org/10.1007/s00401-005-1041-5
Appin CL, Brat DJ (2015) Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis. Adv Anat Pathol 22(1):50–58. https://doi.org/10.1097/PAP.0000000000000048
Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415):770–776
Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272(1): 217–221.
Ballance WC, Qin EC, Chung HJ, Gillette MU, Kong H (2019) Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials 217:119292. https://doi.org/10.1016/j.biomaterials.2019.119292
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760. https://doi.org/10.1038/nature05236
Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205–214. https://doi.org/10.1038/nrd1330
Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3(5):420–425. https://doi.org/10.1093/embo-reports/kvf094
Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6(9):702–713. https://doi.org/10.1038/nrc1950
Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, Den Dunnen WFA, Boddeke H, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP, Aldape K (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24(3):331–346. https://doi.org/10.1016/j.ccr.2013.08.001
Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA, Brain Tumor Epidemiology C (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113(7 Suppl):1953–1968. https://doi.org/10.1002/cncr.23741
Bouras A, Kaluzova M, Hadjipanayis CG (2015) Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles. J Neurooncol 124(1):13–22. https://doi.org/10.1007/s11060-015-1807-0
Bush NA, Chang SM, Berger MS (2017) Current and future strategies for treatment of glioma. Neurosurg Rev 40(1):1–14. https://doi.org/10.1007/s10143-016-0709-8
Byun YJ, Kim SK, Kim YM, Chae GT, Jeong SW, Lee SB (2009) Hydrogen peroxide induces autophagic cell death in C6 glioma cells via BNIP3-mediated suppression of the mTOR pathway. Neurosci Lett 461(2):131–135. https://doi.org/10.1016/j.neulet.2009.06.011
Campos-Martin JM, Blanco-Brieva G, Fierro JL (2006) Hydrogen peroxide synthesis: an outlook beyond the anthraquinone process. Angew Chem Int Ed Engl 45(42):6962–6984. https://doi.org/10.1002/anie.200503779
Chaiswing L, St Clair WH, St Clair DK (2018) Redox paradox: a novel approach to therapeutics-resistant cancer. Antioxid Redox Signal 29(13):1237–1272. https://doi.org/10.1089/ars.2017.7485
Chan D (2018) Precision cancer therapeutics for glioma. Glioma 1:155–158
Chang S, Jiang X, Zhao C, Lee C, Ferriero DM (2008) Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett 441(1):134–138. https://doi.org/10.1016/j.neulet.2008.06.005
Chang KY, Hsu TI, Hsu CC, Tsai SY, Liu JJ, Chou SW, Liu MS, Liou JP, Ko CY, Chen KY, Hung JJ, Chang WC, Chuang CK, Kao TJ, Chuang JY (2017) Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O(6)-methylguanine-DNA methyltransferase. Redox Biol 13:655–664. https://doi.org/10.1016/j.redox.2017.08.005
Chen Q, Liang C, Sun X, Chen J, Yang Z, Zhao H, Feng L, Liu Z (2017) H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay. Proc Natl Acad Sci USA 114(21):5343–5348. https://doi.org/10.1073/pnas.1701976114
Cheng Y, Dai J, Sun C, Liu R, Zhai T, Lou X, Xia F (2018) An Intracellular H2 O2 -responsive AIEgen for the peroxidase-mediated selective imaging and inhibition of inflammatory cells. Angew Chem Int Ed Engl 57(12):3123–3127. https://doi.org/10.1002/anie.201712803
Ciriminna R, Albanese L, Meneguzzo F, Pagliaro M (2016) Hydrogen peroxide: a key chemical for today's sustainable development. Chemsuschem 9(24):3374–3381. https://doi.org/10.1002/cssc.201600895
Cobbs CS, Whisenhunt TR, Wesemann DR, Harkins LE, Van Meir EG, Samanta M (2003) Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res 63(24):8670–8673
Covas G, Marinho HS, Cyrne L, Antunes F (2013) Activation of Nrf2 by H2O2: de novo synthesis versus nuclear translocation. Methods Enzymol 528:157–171. https://doi.org/10.1016/B978-0-12-405881-1.00009-4
Dai B, Gong A, Jing Z, Aldape KD, Kang SH, Sawaya R, Huang S (2013) Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress. J Biol Chem 288(3):1634–1642. https://doi.org/10.1074/jbc.M112.379362
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274):739–744. https://doi.org/10.1038/nature08617
Daniel P, Filiz G, Brown DV, Hollande F, Gonzales M, D'Abaco G, Papalexis N, Phillips WA, Malaterre J, Ramsay RG, Mantamadiotis T (2014) Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation. Oncogenesis 3:e108. https://doi.org/10.1038/oncsis.2014.21
Dhandapani KM, Mahesh VB, Brann DW (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102(2):522–538. https://doi.org/10.1111/j.1471-4159.2007.04633.x
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783. https://doi.org/10.1038/nature07733
Dokic I, Hartmann C, Herold-Mende C, Regnier-Vigouroux A (2012) Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Glia 60(11):1785–1800. https://doi.org/10.1002/glia.22397
Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16(7):966–975. https://doi.org/10.1038/cdd.2009.33
Feng F, Zhang M, Yang C, Heng X, Wu X (2019) The dual roles of autophagy in gliomagenesis and clinical therapy strategies based on autophagic regulation mechanisms. Biomed Pharmacother 120:109441. https://doi.org/10.1016/j.biopha.2019.109441
Forman HJ, Maiorino M, Ursini F (2010) Signaling functions of reactive oxygen species. Biochemistry 49(5):835–842. https://doi.org/10.1021/bi9020378
Furukawa A, Tada-Oikawa S, Kawanishi S, Oikawa S (2007) H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol Biochem 20(1–4):45–54. https://doi.org/10.1159/000104152
Gammoh N, Fraser J, Puente C, Syred HM, Kang H, Ozawa T, Lam D, Acosta JC, Finch AJ, Holland E, Jiang X (2016) Suppression of autophagy impedes glioblastoma development and induces senescence. Autophagy 12(9):1431–1439. https://doi.org/10.1080/15548627.2016.1190053
Gan HK, Kaye AH, Luwor RB (2009) The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci 16(6):748–754. https://doi.org/10.1016/j.jocn.2008.12.005
Gilbert MR, Liu Y, Neltner J, Pu H, Morris A, Sunkara M, Pittman T, Kyprianou N, Horbinski C (2014) Autophagy and oxidative stress in gliomas with IDH1 mutations. Acta Neuropathol 127(2):221–233. https://doi.org/10.1007/s00401-013-1194-6
Go YM, Chandler JD, Jones DP (2015) The cysteine proteome. Free Radic Biol Med 84:227–245. https://doi.org/10.1016/j.freeradbiomed.2015.03.022
Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931–947. https://doi.org/10.1038/nrd4002
Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J, Li M (2012) Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int J Cancer 130(3):593–601. https://doi.org/10.1002/ijc.26049
Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, Zhu S, Kofman AA, Bensinger SJ, Yong WH, Vinters HV, Horvath S, Watson AD, Kuhn JG, Robins HI, Mehta MP, Wen PY, DeAngelis LM, Prados MD, Mellinghoff IK, Cloughesy TF, Mischel PS (2009) EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal 2(101): ra82. https://doi.org/10.1126/scisignal.2000446
Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, Kuga D, Amzajerdi AN, Soto H, Zhu S, Babic I, Tanaka K, Dang J, Iwanami A, Gini B, Dejesus J, Lisiero DD, Huang TT, Prins RM, Wen PY, Robins HI, Prados MD, Deangelis LM, Mellinghoff IK, Mehta MP, James CD, Chakravarti A, Cloughesy TF, Tontonoz P, Mischel PS (2011) An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov 1(5):442–456. https://doi.org/10.1158/2159-8290.CD-11-0102
Guo Z, Xu J, Zhang J, Hu Y, Pan Y, Miao P (2018) A facile strategy for electrochemical analysis of hydrogen peroxide based on multifunctional Fe3O4@Ag nanocomposites. ACS Appl Bio Mater 1(2):367–373
Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1(6):401–408. https://doi.org/10.1016/j.cmet.2005.05.001
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97(6):1634–1658. https://doi.org/10.1111/j.1471-4159.2006.03907.x
Halliwell B (2011) Free radicals and antioxidants—quo vadis? Trends Pharmacol Sci 32(3):125–130. https://doi.org/10.1016/j.tips.2010.12.002
Hoang-Minh LB, Mitchell DA (2018) Immunotherapy for brain tumors. Curr Treat Options Oncol 19(11):60. https://doi.org/10.1007/s11864-018-0576-3
Holley AK, Miao L, St Clair DK, St Clair WH (2014) Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutases. Antioxid Redox Signal 20(10):1567–1589. https://doi.org/10.1089/ars.2012.5000
Hu XQ, Sun Y, Lau E, Zhao M, Su SB (2016) Advances in synergistic combinations of Chinese herbal medicine for the treatment of cancer. Curr Cancer Drug Targets 16(4):346–356
Huang BK, Stein KT, Sikes HD (2016) Modulating and measuring intracellular H2O2 using genetically encoded tools to study its toxicity to human cells. ACS Synth Biol 5(12):1389–1395. https://doi.org/10.1021/acssynbio.6b00120
Im CN, Yun HH, Lee JH (2017) Heat shock factor 1 depletion sensitizes A172 glioblastoma cells to temozolomide via suppression of cancer stem cell-like properties. Int J Mol Sci 18(2):18020468. https://doi.org/10.3390/ijms18020468
Jacquier-Sarlin MR, Polla BS (1996) Dual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxin. Biochem J 318(Pt 1):187–193
Jain KK (2018) A critical overview of targeted therapies for glioblastoma. Front Oncol 8:419. https://doi.org/10.3389/fonc.2018.00419
Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W, Zhang DD (2010) High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 70(13):5486–5496. https://doi.org/10.1158/0008-5472.CAN-10-0713
Joiner A (2006) The bleaching of teeth: a review of the literature. J Dent 34(7):412–419. https://doi.org/10.1016/j.jdent.2006.02.002
Karin M, Shaulian E (2001) AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life 52(1–2):17–24. https://doi.org/10.1080/15216540252774711
Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2(4):301–310. https://doi.org/10.1038/nrc780
Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7(2):134–153. https://doi.org/10.1215/S1152851704001115
Keir ST, Dewhirst MW, Kirkpatrick JP, Bigner DD, Batinic-Haberle I (2011) Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Anticancer Agents Med Chem 11(2):202–212
Kim TH, Song J, Alcantara Llaguno SR, Murnan E, Liyanarachchi S, Palanichamy K, Yi JY, Viapiano MS, Nakano I, Yoon SO, Wu H, Parada LF, Kwon CH (2012) Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth. PLoS ONE 7(8):e42818. https://doi.org/10.1371/journal.pone.0042818
Kim SH, Kwon CH, Nakano I (2014) Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development. J Neurosci Res 92(11):1419–1424. https://doi.org/10.1002/jnr.23431
Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, Lee TH, Chang KT, Hong Y (2015) Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci 16(11):26880–26913. https://doi.org/10.3390/ijms161125991
Kitamura Y, Ota T, Matsuoka Y, Tooyama I, Kimura H, Shimohama S, Nomura Y, Gebicke-Haerter PJ, Taniguchi T (1999) Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells. Glia 25(2):154–164
Klingelhoeffer C, Kammerer U, Koospal M, Muhling B, Schneider M, Kapp M, Kubler A, Germer CT, Otto C (2012) Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med 12:61. https://doi.org/10.1186/1472-6882-12-61
Kondo T (2017) Molecular mechanisms involved in gliomagenesis. Brain Tumor Pathol 34(1):1–7. https://doi.org/10.1007/s10014-017-0278-8
Kopan R (2002) Notch: a membrane-bound transcription factor. J Cell Sci 115(Pt 6):1095–1097
Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392(10145):432–446. https://doi.org/10.1016/S0140-6736(18)30990-5
Lee WC, Choi CH, Cha SH, Oh HL, Kim YK (2005) Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30(2):263–270. https://doi.org/10.1007/s11064-005-2449-y
Lennicke C, Rahn J, Lichtenfels R, Wessjohann LA, Seliger B (2015) Hydrogen peroxide—production, fate and role in redox signaling of tumor cells. Cell Commun Signal 13:39. https://doi.org/10.1186/s12964-015-0118-6
Lenting K, Verhaak R, Ter Laan M, Wesseling P, Leenders W (2017) Glioma: experimental models and reality. Acta Neuropathol 133(2):263–282. https://doi.org/10.1007/s00401-017-1671-4
Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9(10):749–758. https://doi.org/10.1038/nrc2723
Li L, Lin X, Shoemaker AR, Albert DH, Fesik SW, Shen Y (2006) Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo. Clin Cancer Res 12(15):4747–4754. https://doi.org/10.1158/1078-0432.CCR-05-2842
Li F, Wang H, Huang C, Lin J, Zhu G, Hu R, Feng H (2011) Hydrogen peroxide contributes to the manganese superoxide dismutase promotion of migration and invasion in glioma cells. Free Radic Res 45(10):1154–1161. https://doi.org/10.3109/10715762.2011.604321
Li Y, An L, Lin J, Tian Q, Yang S (2019) Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S. Int J Nanomedicine 14:5729–5749. https://doi.org/10.2147/IJN.S210116
Lin LS, Huang T, Song J, Ou XY, Wang Z, Deng H, Tian R, Liu Y, Wang JF, Liu Y, Yu G, Zhou Z, Wang S, Niu G, Yang HH, Chen X (2019) Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy. J Am Chem Soc 141(25):9937–9945
Lino MM, Merlo A, Boulay JL (2010) Notch signaling in glioblastoma: a developmental drug target? BMC Med 8:72. https://doi.org/10.1186/1741-7015-8-72
Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44(5):479–496. https://doi.org/10.3109/10715761003667554
Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z, Wu K, Fan D (2008) Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99(1):121–128. https://doi.org/10.1111/j.1349-7006.2007.00643.x
Liu Q, Sun Y, Zheng JM, Yan XL, Chen HM, Chen JK, Huang HQ (2015) Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5. Int J Clin Exp Pathol 8(6):6434–6441
Liu T, Xu H, Huang M, Ma W, Saxena D, Lustig RA, Alonso-Basanta M, Zhang Z, O'Rourke DM, Zhang L, Gong Y, Kao GD, Dorsey JF, Fan Y (2018) Circulating glioma cells exhibit stem cell-like properties. Cancer Res 78(23):6632–6642. https://doi.org/10.1158/0008-5472.CAN-18-0650
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Luo J, Wang X, Xia Z, Yang L, Ding Z, Chen S, Lai B, Zhang N (2015) Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK). Mol Biol Cell 26(3):430–439. https://doi.org/10.1091/mbc.E14-10-1443
Ma B, Wang S, Liu F, Zhang S, Duan J, Li Z, Kong Y, Sang Y, Liu H, Bu W, Li L (2019) Self-assembled copper-amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy. J Am Chem Soc 141:849–857
Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8(9):741–752. https://doi.org/10.1038/nrm2239
Marangolo M, McGee MM, Tipton KF, Williams DC, Zisterer DM (2001) Oxidative stress induces apoptosis in C6 glioma cells: involvement of mitogen-activated protein kinases and nuclear factor kappa B. Neurotox Res 3(4):397–409
Marchissio MJ, Frances DE, Carnovale CE, Marinelli RA (2012) Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability. Toxicol Appl Pharmacol 264(2):246–254. https://doi.org/10.1016/j.taap.2012.08.005
Marinho HS, Real C, Cyrne L, Soares H, Antunes F (2014) Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol 2:535–562. https://doi.org/10.1016/j.redox.2014.02.006
Marino G, Niso-Santano M, Baehrecke EH, Kroemer G (2014) Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol 15(2):81–94. https://doi.org/10.1038/nrm3735
Matsuda K, Sato A, Okada M, Shibuya K, Seino S, Suzuki K, Watanabe E, Narita Y, Shibui S, Kayama T, Kitanaka C (2012) Targeting JNK for therapeutic depletion of stem-like glioblastoma cells. Sci Rep 2:516. https://doi.org/10.1038/srep00516
Miyauchi JT, Tsirka SE (2018) Advances in immunotherapeutic research for glioma therapy. J Neurol 265(4):741–756. https://doi.org/10.1007/s00415-017-8695-5
Mohammadi M, Taghavi S, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M (2018) Hybrid vesicular drug delivery systems for cancer therapeutics. Adv Funct Mater 28:1802136
Mokhlis GR, Matis BA, Cochran MA, Eckert GJ (2000) A clinical evaluation of carbamide peroxide and hydrogen peroxide whitening agents during daytime use. J Am Dent Assoc 131(9):1269–1277
Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, Nannepaga S, Hatanpaa KJ, Mickey B, Madden C, Maher E, Boothman DA, Furnari F, Cavenee WK, Bachoo RM, Burma S (2009) EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res 69(10):4252–4259. https://doi.org/10.1158/0008-5472.CAN-08-4853
Nagai S, Washiyama K, Kurimoto M, Takaku A, Endo S, Kumanishi T (2002) Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma. J Neurosurg 96(5):909–917. https://doi.org/10.3171/jns.2002.96.5.0909
Natsumeda M, Igarashi H, Nomura T, Ogura R, Tsukamoto Y, Kobayashi T, Aoki H, Okamoto K, Kakita A, Takahashi H, Nakada T, Fujii Y (2014) Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy. Acta Neuropathol Commun 2: 158. https://doi.org/10.1186/s40478-014-0158-y
Niciforovic A, Djordjevic J, Adzic M, Vucic V, Mitrasinovic PM, Radojcic MB (2008) Experimental and systems biology studies of the molecular basis for the radioresistance of prostate carcinoma cells. Ann Biomed Eng 36(5):831–838. https://doi.org/10.1007/s10439-008-9457-4
Nishi H, Maeda N, Izumi S, Higa-Nakamine S, Toku S, Kakinohana M, Sugahara K, Yamamoto H (2015) Differential regulation of epidermal growth factor receptor by hydrogen peroxide and flagellin in cultured lung alveolar epithelial cells. Eur J Pharmacol 748:133–142. https://doi.org/10.1016/j.ejphar.2014.12.016
Nitta M, Kozono D, Kennedy R, Stommel J, Ng K, Zinn PO, Kushwaha D, Kesari S, Inda MM, Wykosky J, Furnari F, Hoadley KA, Chin L, DePinho RA, Cavenee WK, D'Andrea A, Chen CC (2010) Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. PLoS ONE 5(5):e10767. https://doi.org/10.1371/journal.pone.0010767
Noch EK, Ramakrishna R, Magge R (2018) Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance. World Neurosurg 116:505–517. https://doi.org/10.1016/j.wneu.2018.04.022
Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170(5):1445–1453. https://doi.org/10.2353/ajpath.2007.070011
Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19(4):764–772. https://doi.org/10.1158/1078-0432.CCR-12-3002
Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schuler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108(1):49–56. https://doi.org/10.1007/s00401-004-0861-z
Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310(17):1842–1850. https://doi.org/10.1001/jama.2013.280319
Ozgen N, Guo J, Gertsberg Z, Danilo P Jr, Rosen MR, Steinberg SF (2009) Reactive oxygen species decrease cAMP response element binding protein expression in cardiomyocytes via a protein kinase D1-dependent mechanism that does not require Ser133 phosphorylation. Mol Pharmacol 76(4):896–902. https://doi.org/10.1124/mol.109.056473
Pallichankandy S, Rahman A, Thayyullathil F, Galadari S (2015) ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine. Free Radic Biol Med 89:708–720. https://doi.org/10.1016/j.freeradbiomed.2015.10.404
Pan H, Wang H, Zhu L, Mao L, Qiao L, Su X (2013) The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg 80(3–4):363–370. https://doi.org/10.1016/j.wneu.2011.06.063
Panganiban RA, Snow AL, Day RM (2013) Mechanisms of radiation toxicity in transformed and non-transformed cells. Int J Mol Sci 14(8):15931–15958. https://doi.org/10.3390/ijms140815931
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812. https://doi.org/10.1126/science.1164382
Peng J, Yang Q, Li W, Tan L, Xiao Y, Chen L, Hao Y, Qian Z (2017) Erythrocyte-membrane-coated prussian blue/manganese dioxide nanoparticles as H2O2-responsive oxygen generators to enhance cancer chemotherapy/photothermal therapy. ACS Appl Mater Interfaces 9(51):44410–44422. https://doi.org/10.1021/acsami.7b17022
Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM (2012) Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol 107(1):197–205. https://doi.org/10.1007/s11060-011-0737-8
Poschmann G, Grzendowski M, Stefanski A, Bruns E, Meyer HE (1854) Stuhler K (2015) Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress. Biochim Biophys Acta 6:624–631. https://doi.org/10.1016/j.bbapap.2014.11.011
Purdom-Dickinson SE, Sheveleva EV, Sun H, Chen QM (2007) Translational control of nrf2 protein in activation of antioxidant response by oxidants. Mol Pharmacol 72(4):1074–1081. https://doi.org/10.1124/mol.107.035360
Qiao C, Yang J, Shen Q, Liu R, Li Y, Shi Y, Chen J, Shen Y, Xiao Z, Weng J, Zhang X (2018) Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment. Adv Mater 30(18):e1705054. https://doi.org/10.1002/adma.201705054
Rahman A, Thayyullathil F, Pallichankandy S, Galadari S (2016) Hydrogen peroxide/ceramide/Akt signaling axis play a critical role in the antileukemic potential of sanguinarine. Free Radic Biol Med 96:273–289. https://doi.org/10.1016/j.freeradbiomed.2016.05.001
Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, Anver MR, Shoemaker RH, Melillo G (2009) Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther 8(7):1867–1877. https://doi.org/10.1158/1535-7163.MCT-09-0274
Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B, Yan H (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA 108(8):3270–3275. https://doi.org/10.1073/pnas.1019393108
Reitman ZJ, Winkler F, Elia AEH (2018) New directions in the treatment of glioblastoma. Semin Neurol 38(1):50–61. https://doi.org/10.1055/s-0038-1623534
Reszec J, Rutkowski R, Chyczewski L (2013) The expression of hypoxia-inducible factor-1 in primary brain tumors. Int J Neurosci 123(9):657–662. https://doi.org/10.3109/00207454.2013.789874
Rinaldi M, Caffo M, Minutoli L, Marini H, Abbritti RV, Squadrito F, Trichilo V, Valenti A, Barresi V, Altavilla D, Passalacqua M, Caruso G (2016) ROS and brain gliomas: an overview of potential and innovative therapeutic strategies. Int J Mol Sci 17(6): . https://doi.org/10.3390/ijms17060984
Rocha CR, Garcia CC, Vieira DB, Quinet A, de Andrade-Lima LC, Munford V, Belizario JE, Menck CF (2014) Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis 5:e1505. https://doi.org/10.1038/cddis.2014.465
Ru P, Hu P, Geng F, Mo X, Cheng C, Yoo JY, Cheng X, Wu X, Guo JY, Nakano I, Lefai E, Kaur B, Chakravarti A, Guo D (2016) Feedback loop regulation of SCAP/SREBP-1 by miR-29 modulates EGFR signaling-driven glioblastoma growth. Cell Rep 16(6):1527–1535. https://doi.org/10.1016/j.celrep.2016.07.017
Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD, Neve R, Ratan RR (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 23(9):3597–3606
Sai K, Li WY, Chen YS, Wang J, Guan S, Yang QY, Guo CC, Mou YG, Li WP, Chen ZP (2014) Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-kappaB signaling in glioma initiating cells. Am J Chin Med 42(2):485–503. https://doi.org/10.1142/S0192415X14500323
Salazar-Ramiro A, Ramirez-Ortega D, Perez de la Cruz V, Hernandez-Pedro NY, Gonzalez-Esquivel DF, Sotelo J, Pineda B (2016) Role of redox status in development of glioblastoma. Front Immunol 7:156. https://doi.org/10.3389/fimmu.2016.00156
Sanchez-Perez Y, Soto-Reyes E, Garcia-Cuellar CM, Cacho-Diaz B, Santamaria A, Rangel-Lopez E (2017) Role of epigenetics and oxidative stress in gliomagenesis. CNS Neurol Disord Drug Targets 16(10):1090–1098. https://doi.org/10.2174/1871527317666180110124645
Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, Wick W (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14(10):2900–2908. https://doi.org/10.1158/1078-0432.CCR-07-1719
Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Narita Y, Shibui S, Kayama T, Kitanaka C (2014) Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res 12(1):119–131. https://doi.org/10.1016/j.scr.2013.09.012
Scherz-Shouval R, Elazar Z (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36(1):30–38. https://doi.org/10.1016/j.tibs.2010.07.007
Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z (2007) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26(7):1749–1760. https://doi.org/10.1038/sj.emboj.7601623
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10(8):2247–2258
Sekiya M, Hiraishi A, Touyama M, Sakamoto K (2008) Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem Biophys Res Commun 375(4):602–607. https://doi.org/10.1016/j.bbrc.2008.08.068
Seo G, Kim SK, Byun YJ, Oh E, Jeong SW, Chae GT, Lee SB (2011) Hydrogen peroxide induces Beclin 1-independent autophagic cell death by suppressing the mTOR pathway via promoting the ubiquitination and degradation of Rheb in GSH-depleted RAW 264.7 cells. Free Radic Res 45(4): 389–399. https://doi.org/10.3109/10715762.2010.535530
Shadel GS, Horvath TL (2015) Mitochondrial ROS signaling in organismal homeostasis. Cell 163(3):560–569. https://doi.org/10.1016/j.cell.2015.10.001
Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821–861. https://doi.org/10.1146/annurev.biochem.68.1.821
Shi X, Zhang Y, Zheng J, Pan J (2012) Reactive oxygen species in cancer stem cells. Antioxid Redox Signal 16(11):1215–1228. https://doi.org/10.1089/ars.2012.4529
Shi J, Zuo H, Ni L, Xia L, Zhao L, Gong M, Nie D, Gong P, Cui D, Shi W, Chen J (2014) An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation. Neurol Sci 35(6):839–845. https://doi.org/10.1007/s10072-013-1607-2
Shimano H (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40(6):439–452
Sies H (2017) Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol 11:613–619. https://doi.org/10.1016/j.redox.2016.12.035
Smith PS, Zhao W, Spitz DR, Robbins ME (2007) Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress. Free Radic Biol Med 42(6):787–797. https://doi.org/10.1016/j.freeradbiomed.2006.11.032
Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME (2008) Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 45(8):1178–1189. https://doi.org/10.1016/j.freeradbiomed.2008.07.015
Song X, Xu J, Liang C, Chao Y, Jin Q, Wang C, Chen M, Liu Z (2018) Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer. Nano Lett 18(10):6360–6368. https://doi.org/10.1021/acs.nanolett.8b02720
Spitz DR, Azzam EI, Li JJ, Gius D (2004) Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23(3–4):311–322. https://doi.org/10.1023/B:CANC.0000031769.14728.bc
Stone JR, Yang S (2006) Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8(3–4):243–270. https://doi.org/10.1089/ars.2006.8.243
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Organisation E, for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G, (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, Wang X, He C, Pan H (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4:e838. https://doi.org/10.1038/cddis.2013.350
Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270(5234):296–299
Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB (2003) Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278(26):24233–24241. https://doi.org/10.1074/jbc.M212389200
Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J, Yuan J, Qiang B, Peng X (2012) cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc Natl Acad Sci USA 109(39):15805–15810. https://doi.org/10.1073/pnas.1207787109
Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591. https://doi.org/10.1038/nrd2803
Tsai WC, Hueng DY, Lin CR, Yang TC, Gao HW (2016) Nrf2 expressions correlate with WHO grades in gliomas and meningiomas. Int J Mol Sci 17(5):17050722. https://doi.org/10.3390/ijms17050722
Uberti D, Yavin E, Gil S, Ayasola KR, Goldfinger N, Rotter V (1999) Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. Brain Res Mol Brain Res 65(2):167–175
Urban MV, Rath T, Radtke C (2017) Hydrogen peroxide (H2O2): a review of its use in surgery. Wien Med Wochenschr. 169(9–10):222–225. https://doi.org/10.1007/s10354-017-0610-2
Van de Bittner GC, Dubikovskaya EA, Bertozzi CR, Chang CJ (2010) In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci USA 107(50):21316–21321. https://doi.org/10.1073/pnas.1012864107
Venere M, Fine HA, Dirks PB, Rich JN (2011) Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59(8):1148–1154. https://doi.org/10.1002/glia.21185
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research N (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110. https://doi.org/10.1016/j.ccr.2009.12.020
Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS (2017) Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis. Cancer Res 77(4):960–970. https://doi.org/10.1158/0008-5472.CAN-16-2008
Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN (2004) Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest 84(8):941–951. https://doi.org/10.1038/labinvest.3700123
Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B (2009) Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol 182(4):2449–2457. https://doi.org/10.4049/jimmunol.0802770
Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28(1):17–28. https://doi.org/10.1002/stem.261
Wang J, Zhang Y, Archibong E, Ligler F, Gu Z (2017) Leveraging H2O2 levels for biomedical applications. Adv Biosys 1:1700084
Watt BE, Proudfoot AT, Vale JA (2004) Hydrogen peroxide poisoning. Toxicol Rev 23(1):51–57
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. https://doi.org/10.1056/NEJMra0708126
Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61(6):2744–2750
Winterbourn CC (2013) The biological chemistry of hydrogen peroxide. Methods Enzymol 528:3–25. https://doi.org/10.1016/B978-0-12-405881-1.00001-X
Womeldorff M, Gillespie D, Jensen RL (2014) Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus 37(6):E8
Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG (2010) Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140(4):517–528. https://doi.org/10.1016/j.cell.2010.01.009
Wu Y, Wang D, Wang X, Wang Y, Ren F, Chang D, Chang Z, Jia B (2011) Caspase 3 is activated through caspase 8 instead of caspase 9 during H2O2-induced apoptosis in HeLa cells. Cell Physiol Biochem 27(5):539–546. https://doi.org/10.1159/000329955
Xu X, Li J, Han S, Tao C, Fang L, Sun Y, Zhu J, Liang Z, Li F (2016) A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Eur J Pharm Sci 88:178–190. https://doi.org/10.1016/j.ejps.2016.02.015
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765–773. https://doi.org/10.1056/NEJMoa0808710
Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z (2016) Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin Cancer Res 35:23. https://doi.org/10.1186/s13046-016-0303-5
Yang F, Nam S, Brown CE, Zhao R, Starr R, Ma Y, Xie J, Horne DA, Malkas LH, Jove R, Hickey RJ (2014) A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS ONE 9(4):e94443. https://doi.org/10.1371/journal.pone.0094443
Yang W, Shen Y, Wei J, Liu F (2015) MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species. Oncotarget 6(26):22006–22027. https://doi.org/10.18632/oncotarget.4292
Yang Y, Luo H, Hui K, Ci Y, Shi K, Chen G, Shi L, Xu C (2016) Selenite-induced autophagy antagonizes apoptosis in colorectal cancer cells in vitro and in vivo. Oncol Rep 35(3):1255–1264. https://doi.org/10.3892/or.2015.4484
Yang B, Chen Y, Shi J (2019) Nanocatalytic medicine. Adv Mater 31(39):e1901778. https://doi.org/10.1002/adma.201901778
Yao C, Wang W, Wang P, Zhao M, Li X, Zhang F (2018) Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2 O2 -responsive O2 -evolving synergetic cancer therapy. Adv Mater 30(7):1704833. https://doi.org/10.1002/adma.201704833
Ye L, Jia Y, Ji KE, Sanders AJ, Xue K, Ji J, Mason MD, Jiang WG (2015) Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncol Lett 10(3):1240–1250. https://doi.org/10.3892/ol.2015.3459
Yeh SH, Yang WB, Gean PW, Hsu CY, Tseng JT, Su TP, Chang WC, Hung JJ (2011) Translational and transcriptional control of Sp1 against ischaemia through a hydrogen peroxide-activated internal ribosomal entry site pathway. Nucleic Acids Res 39(13):5412–5423. https://doi.org/10.1093/nar/gkr161
Yin Y, Cao L, Ge H, Duanmu W, Tan L, Yuan J, Tunan C, Li F, Hu R, Gao F, Feng H (2017) L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin. NeuroReport 28(9):506–513. https://doi.org/10.1097/WNR.0000000000000792
Yoon SO, Kim MM, Park SJ, Kim D, Chung J, Chung AS (2002) Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J 16(1):111–113. https://doi.org/10.1096/fj.01-0398fje
Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS, An S, Hwang SG, Kang SG, Suh Y, Park MJ, Lee SJ (2012) c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene 31(44):4655–4666. https://doi.org/10.1038/onc.2011.634
Zanganeh S, Georgala P, Corbo C, Arabi L, Ho JQ, Javdani N, Sepand MR, Cruickshank K, Campesato LF, Weng CH, Hemayat S, Andreou C, Alvim R, Hutter G, Rafat M, Mahmoudi M (2019) Immunoengineering in glioblastoma imaging and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 11(6):e1575. https://doi.org/10.1002/wnan.1575
Zhang C, Moore LM, Li X, Yung WK, Zhang W (2013) IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma. Neuro Oncol 15(9):1114–1126. https://doi.org/10.1093/neuonc/not087
Zhang RR, Pointer KB, Kuo JS, Dempsey RJ (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Neurosurgery 75(6):N9–10. https://doi.org/10.1227/NEU.0000000000000580
Zhang L, Wang K, Lei Y, Li Q, Nice EC, Huang C (2015) Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response. Free Radic Biol Med 89:452–465. https://doi.org/10.1016/j.freeradbiomed.2015.08.030
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, Ding J, Lei Q, Guan KL, Xiong Y (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324(5924):261–265. https://doi.org/10.1126/science.1170944
Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W, Kang C, Fu Z, You Y, Jiang T (2012) Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study. BMC Cancer 12:617. https://doi.org/10.1186/1471-2407-12-617
Zhong W, Yan T, Lim R, Oberley LW (1999) Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic Biol Med 27(11–12):1334–1345
Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM, DiMeco F, Vescovi AL, Fan X (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71(18):6061–6072. https://doi.org/10.1158/0008-5472.CAN-10-4269
Zhu J, Wang H, Sun Q, Ji X, Zhu L, Cong Z, Zhou Y, Liu H, Zhou M (2013) Nrf2 is required to maintain the self-renewal of glioma stem cells. BMC Cancer 13:380. https://doi.org/10.1186/1471-2407-13-380
Zhu J, Wang H, Ji X, Zhu L, Sun Q, Cong Z, Zhou Y, Liu H, Zhou M (2014) Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma. Oncol Lett 7(3):693–698. https://doi.org/10.3892/ol.2013.1760
Zhu G, Wang Q, Lu S, Niu Y (2017) Hydrogen peroxide: a potential wound therapeutic target? Med Princ Pract 26(4):301–308. https://doi.org/10.1159/000475501
Acknowledgements
This study was supported by grants from the Startup Fund for Scientific Research, Fujian Medical University (2016QH004 and 2017XQ1003), Fujian Provincial Project of Education and Science for Young and Middle-aged Teachers (JAT170211 and JAT170216), the National Natural Science Foundation of China (81970993), the Natural Science Foundation of Fujian Province (2019J01297), the Medical Innovation Grant of Fujian Province (2019-CX-36), and Fujian Medical University (XRCZX2017019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ying Zhou and Long Wang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhou, Y., Wang, L., Wang, C. et al. Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas. Arch. Pharm. Res. 43, 187–203 (2020). https://doi.org/10.1007/s12272-020-01205-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01205-6